Of course, the work on a vaccine continues. No vaccine technology is certain, but we have already bought six different vaccines and there are more than 100 in development around the world. That is what underpins the strategy, and the work on the leading vaccines, including the AstraZeneca Oxford vaccine, continues effectively. We have seen, both here and overseas, just how quickly the virus can take hold, and we have to act now to get it under control.
Public Health: Coronavirus Regulations
Proceeding contribution from
Matt Hancock
(Conservative)
in the House of Commons on Tuesday, 13 October 2020.
It occurred during Debates on delegated legislation on Public Health: Coronavirus Regulations.
About this proceeding contribution
Reference
682 c194 Session
2019-21Chamber / Committee
House of Commons chamberSubjects
Legislation
Health Protection (Coronavirus, Restrictions) (Obligations of Undertakings) (England) Regulations 2020Health Protection (Coronavirus, Collection of Contact Details etc and Related Requirements) Regulations 2020
Health Protection (Coronavirus, Restrictions) (No. 2) (England) (Amendment) (No. 5) Regulations 2020
Health Protection (Coronavirus, Restrictions) (Obligations of Undertakings) (England) (Amendment) Regulations 2020
Health Protection (Coronavirus, Local COVID-19 Alert Level) (High) (England) Regulations 2020
Health Protection (Coronavirus, Local COVID-19 Alert Level) (Medium) (England) Regulations 2020
Health Protection (Coronavirus, Local COVID-19 Alert Level) (Very High) (England) Regulations 2020
Librarians' tools
Timestamp
2023-04-12 14:19:04 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2020-10-13/20101342000603
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2020-10-13/20101342000603
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2020-10-13/20101342000603